RAMP1 and thyroid gland carcinoma: Although expression of these genes was sensitive to loss of IFT57 but not CD47 in thyroid carcinoma cells, a majority showed positive or negative coexpression with CD47 mRNA in the tumors that paralleled their IFT57 coexpression (e.g., RAMP1, Figure 6b).